Evidence map›Paper›PMID 17901128›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2008

Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor.

Yongyou Zhang, Kerstin McKeehan, Yongshun Lin, Jue Zhang, Fen Wang

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  3. Review
  4. Review
  5. FGF-Dependent, Context-Driven Role for FRS Adapters in the Early Telencephalon.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  6. Article
  7. Fibroblast growth factors, old kids on the new block.Seminars in cell & developmental biology · 2016
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yongyou ZhangCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, 2121 West Holcombe Boulevard, Houston, Texas 77030-3303. fwang@ibt.tamhsc.edu.
Kerstin McKeehan
Yongshun Lin
Jue Zhang
Fen Wang
Texas A&M Health Science Center · US

Funding

Receptor-specific signaling of FGFR in the prostateR01CA096824 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WANG, FEN · 2003 to 2013
$2.5M
FRS2-mediated Signals in Prostatic Tumorigenesis and DevelopmentR56CA096824 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WANG, FEN · 2008 to 2008
$302k
NCI NIH HHS CA96824NCI NIH HHS R01 CA096824NCI NIH HHS R56 CA096824
6 · The paper itself

Abstract

Binding of the fibroblast growth factor (FGF) to the FGF receptor (FGFR) tyrosine kinase leads to receptor tyrosine autophosphorylation as well as phosphorylation of multiple downstream signaling molecules that are recruited to the receptor either by direct binding or through adaptor proteins. The FGFR substrate 2 (FRS2) family consists of two members, FRS2alpha and FRS2beta, and has been shown to recruit multiple signaling molecules, including Grb2 and Shp2, to FGFR1. To better understand how FRS2 interacted with FGFR1, in vivo binding assays with coexpressed FGFR1 and FRS2 recombinant proteins in mammalian cells were carried out. The results showed that the interaction of full-length FRS2alpha, but not FRS2beta, with FGFR1 was enhanced by activation of the receptor kinase. The truncated FRS2alpha mutant that was comprised only of the phosphotyrosine-binding domain (PTB) bound FGFR1 constitutively, suggesting that the C-terminal sequence downstream the PTB domain inhibited the PTB-FGFR1 binding. Inactivation of the FGFR1 kinase and substitutions of tyrosine phosphorylation sites of FGFR1, but not FRS2alpha, reduced binding of FGFR1 with FRS2alpha. The results suggest that although the tyrosine autophosphorylation sites of FGFR1 did not constitute the binding sites for FRS2alpha, phosphorylation of these residues was essential for optimal interaction with FRS2alpha. In addition, it was demonstrated that the Grb2-binding sites of FRS2alpha are essential for mediating signals of FGFR1 to activate the FiRE enhancer of the mouse syndecan 1 gene. The results, for the first time, demonstrate the specific signals mediated by the Grb2-binding sites and further our understanding of FGF signal transmission at the adaptor level.

Indexed as

3T3 CellsAdaptor Proteins, Signal TransducingAnimalsBlotting, WesternCell LineCells, CulturedEmbryonic Stem CellsFibroblastsGRB2 Adaptor ProteinHumansMembrane ProteinsMiceMutationPhosphorylationProtein BindingProtein Tyrosine Phosphatase, Non-Receptor Type 11Adaptor Proteins, Signal TransducingFRS2alpha protein, mouseFrs3 protein, mouseGRB2 Adaptor ProteinGrb2 protein, mouseMembrane ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11Ptpn11 protein, mouseReceptor, Fibroblast Growth Factor, Type 1Tyrosine

Identifiers

PMID17901128
PMCPMC2194630
OpenAlexW2009112707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.